Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quinazolinones | 1 | 2021 | 15 | 0.740 |
Why?
|
| Acrylamides | 1 | 2021 | 34 | 0.740 |
Why?
|
| Aniline Compounds | 1 | 2021 | 60 | 0.720 |
Why?
|
| Mutation | 3 | 2021 | 4203 | 0.570 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 2347 | 0.570 |
Why?
|
| Receptor, ErbB-3 | 1 | 2016 | 19 | 0.520 |
Why?
|
| Urothelium | 1 | 2016 | 64 | 0.500 |
Why?
|
| Urologic Neoplasms | 1 | 2016 | 74 | 0.480 |
Why?
|
| Quinazolines | 1 | 2016 | 214 | 0.470 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 2380 | 0.460 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 255 | 0.450 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 591 | 0.420 |
Why?
|
| Mentors | 1 | 2014 | 93 | 0.410 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 112 | 0.410 |
Why?
|
| Patient Selection | 1 | 2016 | 685 | 0.390 |
Why?
|
| Immunotherapy | 2 | 2023 | 702 | 0.380 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 179 | 0.370 |
Why?
|
| Students, Medical | 1 | 2014 | 427 | 0.310 |
Why?
|
| Clinical Competence | 1 | 2014 | 800 | 0.300 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2023 | 113 | 0.190 |
Why?
|
| Lactams | 1 | 2021 | 11 | 0.190 |
Why?
|
| Retreatment | 1 | 2021 | 107 | 0.180 |
Why?
|
| Ipilimumab | 2 | 2023 | 60 | 0.180 |
Why?
|
| Aminopyridines | 1 | 2021 | 41 | 0.180 |
Why?
|
| Neoplasms | 1 | 2016 | 3053 | 0.180 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 134 | 0.170 |
Why?
|
| Pyrazoles | 1 | 2021 | 152 | 0.170 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6847 | 0.170 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 306 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2021 | 887 | 0.150 |
Why?
|
| ErbB Receptors | 1 | 2021 | 499 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 667 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 613 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 1066 | 0.140 |
Why?
|
| Disease Progression | 1 | 2021 | 1493 | 0.130 |
Why?
|
| Volunteers | 1 | 2014 | 22 | 0.110 |
Why?
|
| Aged | 3 | 2021 | 19574 | 0.110 |
Why?
|
| beta Catenin | 1 | 2015 | 267 | 0.100 |
Why?
|
| Peer Group | 1 | 2014 | 89 | 0.100 |
Why?
|
| Breast | 1 | 2015 | 289 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 178 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2014 | 313 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2021 | 4367 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 175 | 0.100 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 444 | 0.100 |
Why?
|
| Middle Aged | 3 | 2021 | 26555 | 0.090 |
Why?
|
| Humans | 7 | 2023 | 91073 | 0.090 |
Why?
|
| Logistic Models | 1 | 2014 | 1216 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 968 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 1404 | 0.080 |
Why?
|
| Female | 4 | 2021 | 47186 | 0.070 |
Why?
|
| Male | 3 | 2021 | 43249 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 2682 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2615 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2023 | 215 | 0.050 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2021 | 20 | 0.050 |
Why?
|
| Adult | 2 | 2021 | 27147 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 167 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 429 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 339 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 1138 | 0.040 |
Why?
|
| Biopsy | 1 | 2021 | 1196 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 1327 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 378 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 557 | 0.030 |
Why?
|
| Cell Movement | 1 | 2015 | 793 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 1295 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1695 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 6502 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 11993 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 27783 | 0.010 |
Why?
|